Stay updated on Tucatinib Combo Efficacy in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib Combo Efficacy in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib Combo Efficacy in HER2+ Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The old and new screenshots show the same version history entries with a different visual layout, and no substantive trial data or status changes are visible. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T01:23:15.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    Adds a government funding notice, confirms NIH Clinical Center is open, and updates to 2025-09-30, recruitment status, study status, contacts/locations, and software revision to v3.2.0; removes the old non-recruiting status, an earlier date, and previous revision v3.1.0.
    Difference
    11%
    Check dated 2025-10-05T10:30:19.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0.
    Difference
    0.2%
    Check dated 2025-09-28T03:26:00.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; 'Back to Top' UI element removed.
    Difference
    0.6%
    Check dated 2025-09-13T17:45:24.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.
    Difference
    0.6%
    Check dated 2025-09-06T15:24:51.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The web page has added a facility name and location details, while removing specific state, country, and city information. This indicates a shift towards a more generalized presentation of location data.
    Difference
    45%
    Check dated 2025-08-30T12:08:42.000Z thumbnail image

Stay in the know with updates to Tucatinib Combo Efficacy in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib Combo Efficacy in HER2+ Breast Cancer Clinical Trial page.